COVID-19 Collection

Journal article

Successful treatment of refractory chilblain lupus erythematosus with bosentan

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Gunawardana, S., Clarke, A. J., Lloyd-Lavery, A., & Dubey, S. (2025). Successful treatment of refractory chilblain lupus erythematosus with bosentan. Rheumatology, 64(12), 6430–6431.

MLA Style

Gunawardana, S, et al. “Successful Treatment of Refractory Chilblain Lupus Erythematosus with Bosentan.” Rheumatology, vol. 64, no. 12, 2025, pp. 6430–31.

Chicago Style

Gunawardana, S, AJ Clarke, A Lloyd-Lavery, and S Dubey. 2025. “Successful Treatment of Refractory Chilblain Lupus Erythematosus with Bosentan.” Rheumatology 64 (12): 6430–31.
Print

Access Document

Files:: Gunawardana_et_al_2025_Successful_treatment_of.pdf

(Preview, Version of record, pdf, 399.0KB, Terms of use)

Publisher copy:: 10.1093/rheumatology/keaf444

Authors

+ Gunawardana, S More by this author

Institution:: University of Oxford
Role:: Author
ORCID:: 0000-0002-2742-8475

+ Clarke, AJ More by this author

Institution:: University of Oxford
Role:: Author
ORCID:: 0000-0003-2846-7860

+ Lloyd-Lavery, A More by this author

Institution:: University of Oxford
Role:: Author
ORCID:: 0000-0002-2339-0596

+ Dubey, S More by this author

Institution:: University of Oxford
Role:: Author
ORCID:: 0000-0002-9979-6066

Publisher:: Oxford University Press
Journal:: Rheumatology More from this journal
Volume:: 64
Issue:: 12
Pages:: 6430-6431
Publication date:: 2025-08-13
Acceptance date:: 2025-08-01
DOI:: 10.1093/rheumatology/keaf444
EISSN:: 1462-0332
ISSN:: 1462-0324

Language:: English
Keywords:: Dermatology

Medicine

Refractory (planetary science)

Lupus erythematosus

Bosentan

Hydroxychloroquine

Immunology

Internal medicine

Coronavirus disease 2019 (COVID-19)

Disease

Endothelin receptor

Materials science
UUID:: uuid_a531d961-6427-49ce-99da-3e813b665ba0
Source identifiers:: 3528392
Deposit date:: 2025-12-03
ARK identifier:: ark:/29072/ora_a531d961642749ce99da3e813b665ba0

Terms of use

Copyright date:: 2025

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP